*Department of General Surgery and Transplantation, Sant'Orsola-Malpighi Hospital, University of Bologna, Italy †Department of General Surgery, Infermi Hospital, Rimini, Italy ‡Pancreatic Surgery, Department of Surgery, IRCCS Humanitas, University of Milan, Italy §Regina Elena National Cancer Institute, Rome, Italy.
Ann Surg. 2014 Nov;260(5):871-5; discussion 875-7. doi: 10.1097/SLA.0000000000000975.
To optimize the results of low-volume (LV) centers for hepatopancreaticobiliary (HPB) surgery.
High-volume (HV) centers for HPB surgery have lower mortality than LV. Strategies for collaboration between HV and LV centers are not well investigated.
Postoperative outcomes of patients undergoing curative HPB resection were evaluated at an LV hospital before (2006-2008) and during the collaboration (2009-2012) and at 2 hospitals with HV for either liver or pancreatic resection (2009-2012). Itinerant tutor surgeons from the HV centers were involved in the pre-, intra- and postoperative course of HPB patients at the LV hospital.
HPB cases at the LV center increased from 18 to 40 patients per year from 2006 to 2012, whereas 6-month postoperative mortality decreased from 17.8% (2006-2008) to 6% (2009-2012), P<0.05 (liver: 10.3% vs 4.7% and pancreas: 29.4% vs 7.9%). During the collaborative study period, outcomes for hepatectomy were similar for LV and HV (85 vs 507 cases): postoperative Clavien-Dindo scores 4 and 5 were 2% and 0.2% for HV versus 2.4% and 1.2% for LV, respectively. Outcomes for pancreatic procedures (LV 63 vs HV 269 cases) showed better postoperative Clavien-Dindo scores 4 and 5 in the HV (0.7% score 4 and 1.5% score 5 for HV vs 3.2% and 6.3%, respectively, for LV) but the difference disappeared in the last 2 years (2011-2012) and matching the cases.
Our partnership model helped improve postoperative outcomes at the LV center. Results at the LV hospital were comparable with the HV centers, although 2 years of partnership were required to achieve this in pancreatic surgery.
优化低容量(LV)肝胆胰中心的手术结果。
肝胆胰手术的高容量(HV)中心的死亡率低于低容量中心。HV 和 LV 中心之间合作的策略尚未得到充分研究。
在一所 LV 医院评估接受根治性肝胆胰切除术的患者术后结果,该 LV 医院在合作之前(2006-2008 年)和合作期间(2009-2012 年)以及在 2 家具有肝或胰腺切除术 HV 的医院进行(2009-2012 年)。来自 HV 中心的巡回导师外科医生参与了 LV 医院肝胆胰患者的术前、术中和术后过程。
从 2006 年到 2012 年,LV 中心的肝胆胰病例从每年 18 例增加到 40 例,而 6 个月的术后死亡率从 17.8%(2006-2008 年)降至 6%(2009-2012 年),P<0.05(肝:10.3%比 4.7%和胰腺:29.4%比 7.9%)。在合作研究期间,LV 和 HV 之间肝切除术的结果相似(LV 507 例和 HV 85 例):术后 Clavien-Dindo 评分 4 和 5 分别为 HV 组的 2%和 0.2%和 LV 组的 2.4%和 1.2%。胰腺手术的结果(LV 63 例和 HV 269 例)显示 HV 组术后 Clavien-Dindo 评分 4 和 5 更好(HV 组分别为 0.7%评分 4 和 1.5%评分 5,LV 组分别为 3.2%和 6.3%),但在最后 2 年(2011-2012 年)和匹配病例中差异消失。
我们的合作模式有助于改善 LV 中心的术后结果。LV 医院的结果与 HV 中心相当,尽管胰腺手术需要 2 年的合作才能实现这一目标。